NCT01539083 2025-02-04
VCAT
Janssen Scientific Affairs, LLC
Phase 3 Completed
Clinical Trials
3 trialsNCT00985959 2013-12-02
A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)
Janssen Pharmaceutical K.K.
Phase 1 Completed
NCT01179490 2013-03-18
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
SymBio Pharmaceuticals
Phase 2 Terminated